Literature DB >> 8104786

Conditional immortalization of mouse myelomonocytic, megakaryocytic and mast cell progenitors by the Hox-2.4 homeobox gene.

A C Perkins1, S Cory.   

Abstract

The murine myelomonocytic cell line WEHI-3B exhibits ectopic expression of the genes encoding the homeobox protein, Hox-2.4, and the myeloid growth factor, interleukin-3 (IL-3). We showed previously that concomitant expression of IL-3 and Hox-2.4 in bone marrow cells induced the development of transplantable growth factor-independent tumours resembling the WEHI-3B tumour. We have now investigated the effect of enforced expression of Hox-2.4 alone. Bone marrow cells were infected with Hox-2.4 retrovirus and then either cultured in agar or transplanted into irradiated mice. In vitro, colonies derived from virus-infected cells readily yielded IL-3-dependent, non-tumorigenic cell lines of the myelomonocytic, megakaryocytic and mast cell lineages. Surprisingly, both the establishment and maintenance of these lines required very high concentrations of IL-3 and reduced levels promoted differentiation. Transplanted mice analysed after 3 months appeared normal but their spleen and bone marrow contained abundant provirus-bearing progenitor cells, from which IL-3-dependent long-term cell lines could readily be established in vitro. Four of 18 animals monitored for up to 12 months eventually developed clonal leukaemia, associated in three cases with IL-3 production. Thus ectopic expression of Hox-2.4 enhances self-renewal of immature myeloid progenitors and progression to a fully malignant state is favoured by somatic mutations conferring autocrine production of IL-3.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8104786      PMCID: PMC413667          DOI: 10.1002/j.1460-2075.1993.tb06062.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  60 in total

Review 1.  Oncogenes, antioncogenes, and the molecular bases of multistep carcinogenesis.

Authors:  R A Weinberg
Journal:  Cancer Res       Date:  1989-07-15       Impact factor: 12.701

2.  Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome.

Authors:  G Q Daley; R A Van Etten; D Baltimore
Journal:  Science       Date:  1990-02-16       Impact factor: 47.728

3.  Rates of mutation to growth factor autonomy and tumorigenicity differ in hematopoietic stem and precursor cells expressing the multilineage colony-stimulating factor gene.

Authors:  C Laker; N Kluge; C Stocking; U Just; M J Franz; W Ostertag; J F DeLamarter; M Dexter; E Spooncer
Journal:  Mol Cell Biol       Date:  1989-12       Impact factor: 4.272

4.  The murine and Drosophila homeobox gene complexes have common features of organization and expression.

Authors:  A Graham; N Papalopulu; R Krumlauf
Journal:  Cell       Date:  1989-05-05       Impact factor: 41.582

5.  Growth factor gene activation and clonal heterogeneity in an autostimulatory myeloid leukemia.

Authors:  K B Leslie; J W Schrader
Journal:  Mol Cell Biol       Date:  1989-06       Impact factor: 4.272

6.  A new homeobox gene contributes the DNA binding domain of the t(1;19) translocation protein in pre-B ALL.

Authors:  M P Kamps; C Murre; X H Sun; D Baltimore
Journal:  Cell       Date:  1990-02-23       Impact factor: 41.582

7.  Chromosomal translocation t(1;19) results in synthesis of a homeobox fusion mRNA that codes for a potential chimeric transcription factor.

Authors:  J Nourse; J D Mellentin; N Galili; J Wilkinson; E Stanbridge; S D Smith; M L Cleary
Journal:  Cell       Date:  1990-02-23       Impact factor: 41.582

8.  Nonneoplastic hematopoietic myeloproliferative syndrome induced by dysregulated multi-CSF (IL-3) expression.

Authors:  J M Chang; D Metcalf; R A Lang; T J Gonda; G R Johnson
Journal:  Blood       Date:  1989-05-01       Impact factor: 22.113

9.  In vivo transformation of factor-dependent hemopoietic cells: role of intracisternal A-particle transposition for growth factor gene activation.

Authors:  U Dührsen; J Stahl; N M Gough
Journal:  EMBO J       Date:  1990-04       Impact factor: 11.598

10.  DNA rearrangement of a homeobox gene in myeloid leukaemic cells.

Authors:  C Blatt; D Aberdam; R Schwartz; L Sachs
Journal:  EMBO J       Date:  1988-12-20       Impact factor: 11.598

View more
  30 in total

1.  Meis proteins are major in vivo DNA binding partners for wild-type but not chimeric Pbx proteins.

Authors:  C P Chang; Y Jacobs; T Nakamura; N A Jenkins; N G Copeland; M L Cleary
Journal:  Mol Cell Biol       Date:  1997-10       Impact factor: 4.272

2.  High miR-196a levels promote the oncogenic phenotype of colorectal cancer cells.

Authors:  Carl Christoph Schimanski; Kirsten Frerichs; Fareed Rahman; Martin Berger; Hauke Lang; Peter R Galle; Markus Moehler; Ines Gockel
Journal:  World J Gastroenterol       Date:  2009-05-07       Impact factor: 5.742

3.  The oncoprotein E2A-Pbx1a collaborates with Hoxa9 to acutely transform primary bone marrow cells.

Authors:  U Thorsteinsdottir; J Krosl; E Kroon; A Haman; T Hoang; G Sauvageau
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

4.  Retroviral transduction of TLS-ERG initiates a leukemogenic program in normal human hematopoietic cells.

Authors:  D S Pereira; C Dorrell; C Y Ito; O I Gan; B Murdoch; V N Rao; J P Zou; E S Reddy; J E Dick
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-07       Impact factor: 11.205

5.  Hoxa9 transforms primary bone marrow cells through specific collaboration with Meis1a but not Pbx1b.

Authors:  E Kroon; J Krosl; U Thorsteinsdottir; S Baban; A M Buchberg; G Sauvageau
Journal:  EMBO J       Date:  1998-07-01       Impact factor: 11.598

6.  No milk today (my Hox have gone away).

Authors:  D Duboule
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-19       Impact factor: 11.205

Review 7.  Transcriptional regulation during myelopoiesis.

Authors:  N Lenny; J J Westendorf; S W Hiebert
Journal:  Mol Biol Rep       Date:  1997-08       Impact factor: 2.316

Review 8.  Optimizing autologous cell grafts to improve stem cell gene therapy.

Authors:  Nikoletta Psatha; Garyfalia Karponi; Evangelia Yannaki
Journal:  Exp Hematol       Date:  2016-04-19       Impact factor: 3.084

9.  Conditional MN1-TEL knock-in mice develop acute myeloid leukemia in conjunction with overexpression of HOXA9.

Authors:  Hiroyuki Kawagoe; Gerard C Grosveld
Journal:  Blood       Date:  2005-08-16       Impact factor: 22.113

10.  Thrombopoietin, flt3-ligand and c-kit-ligand modulate HOX gene expression in expanding cord blood CD133 cells.

Authors:  C P McGuckin; N Forraz; R Pettengell; A Thompson
Journal:  Cell Prolif       Date:  2004-08       Impact factor: 6.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.